Barely Significant
← all excerpts

Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19.

Am J Med · 2022 · PMC8381625 · PMID 34437834

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP < .001actually significant
Overall, 140 of 349 (40.1%) assigned hydroxychloroquine reported a side effect by day 5, as compared with 50 of 352 (16.8%) assigned placebo, a highly significant increase ( P < .001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.